Clinical trial
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
NCT00003546 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003546 |
|---|---|
| Title | Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer |
| Official title | Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | gemcitabine hydrochloride, radiation therapy |
| Enrollment | 43 |
| Start date | Sep 1, 1998 |
| Primary completion | Dec 1, 2003 |
| Completion | Jan 1, 2006 |
| First posted | Sep 13, 2004 |
| Last update posted | Jul 20, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: